Clinical Trial Update: Mifamurtide (L-MTP-PE) for High-Risk Osteosarcoma

View source ↗

Summary

The entry reports the completion of a clinical trial evaluating mifamurtide (L-MTP-PE) for high-risk osteosarcoma, summarizing outcomes for safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• Mifamurtide (L-MTP-PE) (mifamurtide)

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Osteosarcoma | Status: COMPLETED